CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in cases of chronic pain diseases
3.4.1.2. Technological advancements in analgesic pumps
3.4.1.3. Increase in number of surgeries
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding analgesia pumps
3.4.2.2. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Lucrative growth opportunities in developing countries
3.4.3.2. Development in analgesic pumps
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electronic and Wireless
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Mechanical
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology and hematology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Gastroenterology
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End user
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Ace-medical
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Arcomed AG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. B. Braun SE
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Becton, Dickinson and Company
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Henan Tuoren Medical Device Co., Ltd.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. ICU Medical, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Micrel Medical Devices SA
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Fresenius SE and Co. KGaA
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Changzhou Medical Bioengineering Co., Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. SCW Medicath Ltd
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
TABLE 01. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 05. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 08. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 09. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 17. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 18. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 20. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 23. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 25. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 30. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 31. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 32. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 33. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 35. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 36. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 38. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 44. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 47. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 52. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 54. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 55. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 57. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 58. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 60. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 63. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 69. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 72. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 74. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 76. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 79. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 80. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. ACE-MEDICAL: KEY EXECUTIVES
TABLE 87. ACE-MEDICAL: COMPANY SNAPSHOT
TABLE 88. ACE-MEDICAL: PRODUCT SEGMENTS
TABLE 89. ACE-MEDICAL: PRODUCT PORTFOLIO
TABLE 90. ARCOMED AG: KEY EXECUTIVES
TABLE 91. ARCOMED AG: COMPANY SNAPSHOT
TABLE 92. ARCOMED AG: PRODUCT SEGMENTS
TABLE 93. ARCOMED AG: PRODUCT PORTFOLIO
TABLE 94. B. BRAUN SE: KEY EXECUTIVES
TABLE 95. B. BRAUN SE: COMPANY SNAPSHOT
TABLE 96. B. BRAUN SE: PRODUCT SEGMENTS
TABLE 97. B. BRAUN SE: PRODUCT PORTFOLIO
TABLE 98. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 99. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 101. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 102. HENAN TUOREN MEDICAL DEVICE CO., LTD.: KEY EXECUTIVES
TABLE 103. HENAN TUOREN MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
TABLE 104. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT SEGMENTS
TABLE 105. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
TABLE 106. ICU MEDICAL, INC.: KEY EXECUTIVES
TABLE 107. ICU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 108. ICU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 109. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 110. ICU MEDICAL, INC.: KEY STRATERGIES
TABLE 111. MICREL MEDICAL DEVICES SA: KEY EXECUTIVES
TABLE 112. MICREL MEDICAL DEVICES SA: COMPANY SNAPSHOT
TABLE 113. MICREL MEDICAL DEVICES SA: PRODUCT SEGMENTS
TABLE 114. MICREL MEDICAL DEVICES SA: PRODUCT PORTFOLIO
TABLE 115. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
TABLE 116. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
TABLE 117. FRESENIUS SE AND CO. KGAA: PRODUCT SEGMENTS
TABLE 118. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 119. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: KEY EXECUTIVES
TABLE 120. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
TABLE 121. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT SEGMENTS
TABLE 122. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
TABLE 123. SCW MEDICATH LTD: KEY EXECUTIVES
TABLE 124. SCW MEDICATH LTD: COMPANY SNAPSHOT
TABLE 125. SCW MEDICATH LTD: PRODUCT SEGMENTS
TABLE 126. SCW MEDICATH LTD: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/